The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Aptinyx, Inc. Common 03836N103 21,755 5,215,748 SH   SOLE   5,215,748 0 0
Corvus Pharmaceuticals, Inc. Common 221015100 8,910 3,275,616 SH   SOLE   3,275,616 0 0
Docusign, Inc. Common 256163106 5,073 29,458 SH   OTR   29,458 0 0
Epizyme, Inc. Common 29428V104 912 56,780 SH   OTR   56,780 0 0
Fusion Pharmaceuticals, Inc. Common 36118A100 55,069 3,502,425 SH   SOLE   3,502,425 0 0
IVERIC Bio, Inc. Common 46583P102 1,574 308,539 SH   OTR   308,539 0 0
Paylocity Holding Corporation Common 70438V106 166,100 1,138,528 SH   SOLE   1,138,528 0 0
Q2 Holdings, Inc. Common 74736L109 92,444 1,077,562 SH   SOLE   1,077,562 0 0
Rimini Street, Inc. Common 76674Q107 122,026 23,694,465 SH   SOLE   23,694,465 0 0
Slack Technologies, Inc. Common- Class A 83088V102 8,768 282,005 SH   OTR   282,005 0 0
Zuora, Inc. Common-Class A 98983V106 927 72,714 SH   OTR   72,714 0 0